A study conducted by researchers at the University of Hyderabad discovered that 84% of IT employees are affected by Metabolic ...

Metabolic dysfunction–associated steatohepatitis (MASH) is the new term for non-alcoholic steatohepatitis (NASH). There are ...

Taking care of your gut and liver doesn’t necessarily require an elaborate supplement regime or restrictive diet—sometimes, ...

Intellia’s stock fell 23% after one patient in its Phase III MAGNITUDE trial developed severe liver toxicity that later ...

SaveHealth provides an in-depth look at cholesterol-fighting atorvastatin, its mechanism of action, clinical significance, ...

Apostle Dr. Kadmiel E.H. Agbelenyo, Founder and Leader of the Seventh Day Theocracy World Congregation, has called on ...

Hundreds are gathering to support research and education at the Liver Life Walk, an event inspiring hope through stories of ...

At DDW 2025, researchers presented their findings on the effects of MAFLD on outcomes of patients with hepatocellular carcinoma.

Hyperbilirubinemia is common symptom in many liver diseases, and it's tough to tell the difference early on. However, this is not guaranteed, and understanding enzyme levels is necessary to detect and ...

Metabolic-associated fatty liver disease is prevalent in children and adolescents with severe obesity, with higher insulin ...

Preliminary data from ongoing Phase 1/2 trials show BEAM-302 is well tolerated and achieves dose-dependent, durable ...

The natural history of chronic hepatitis B virus (HBV) infection is driven by complex interactions among virological, host, ...